Inflectra and Injection site pruritus - a phase IV clinical study of FDA data

Summary:

Injection site pruritus is reported as a side effect among people who take Inflectra (infliximab-dyyb), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Humira, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Injection site pruritus when taking Inflectra. It is created by eHealthMe based on reports of 52,342 people who have side effects when taking Inflectra from the FDA, and is updated regularly.

What is Inflectra?

Inflectra has active ingredients of infliximab-dyyb. eHealthMe is studying from 52,370 Inflectra users. Check the latest studies of Inflectra.

What is Injection site pruritus?

Injection site pruritus (severe itching at injection site) is found to be associated with 991 drugs and 1,101 conditions by eHealthMe. Check the latest studies of Injection site pruritus.

On Jul, 09, 2026

52,342 people reported to have side effects when taking Inflectra.
Among them, 28 people (0.05%) have Injection site pruritus.

Could Inflectra cause Injection site pruritus?

Among these 28 people:

How long have people been on Inflectra when they have Injection site pruritus? *

What is the gender of people who have Injection site pruritus when taking Inflectra? *

female: 75 %
male: 25 %

What is the age of people who have Injection site pruritus when taking Inflectra? *

What are other drugs people take besides Inflectra? *

What are other side effects people have besides Injection site pruritus? *

Pain: 23 people, 82.14%
Fatigue (feeling of tiredness): 16 people, 57.14%
Itching: 15 people, 53.57%
Nausea (feeling of having an urge to vomit): 14 people, 50.00%
High Blood Pressure: 13 people, 46.43%
Rashes (redness): 12 people, 42.86%
Dyspnea (difficult or laboured breathing): 11 people, 39.29%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 35.71%
Muscle Spasms (muscle contraction): 10 people, 35.71%
Nosebleed (bleeding from nose): 10 people, 35.71%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 11 people, 39.29%
Ankylosing Spondylitis (type of arthritis affecting the spine): 11 people, 39.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 10.71%
Nausea (feeling of having an urge to vomit): 3 people, 10.71%
Fungal Infection: 3 people, 10.71%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 7.14%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Inflectra and have Injection site pruritus?

- Check whether Injection site pruritus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Inflectra:

Inflectra (52,370 reports)

Browse all side effects of Inflectra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site pruritus:

Injection site pruritus (991 drugs)

Browse all the conditions that are associated with Injection site pruritus:

Injection site pruritus (1,101 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab-dyyb (the active ingredients of Inflectra) and Inflectra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.